Genetic testing for Lynch syndrome in individuals newly diagnosed with colorectal cancer to reduce morbidity and mortality from colorectal cancer in their relatives

PLoS Currents

Volumn , Issue , 2011, Pages

  Coates, Ralph ^a   Williams, Marc ^b   Melillo, Stephanie ^c   Gudgeon, Jim ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c Intermountain Healthcare ^*

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MLH1; B RAF KINASE;

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CELL REGENERATION; COLORECTAL CANCER; DIAGNOSTIC TEST; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; GENE MUTATION; GENETIC SCREENING; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MORBIDITY; PUBLIC HEALTH; SCREENING; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DNA REPAIR; FAMILY HISTORY; GENETIC ANALYSIS; HISTOLOGY; HISTOPATHOLOGY; PRACTICE GUIDELINE; RISK REDUCTION; SCORING SYSTEM; SCREENING TEST;

EID: 84867459083     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1246     Document Type: Article

References (21)

1. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009 Jan;11(1):35-41. PubMed PMID: 19125126; PubMed Central PMCID: PMC2743612.
2. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009 Jan;11(1):42-65. Review. PubMed PMID: 19125127; PubMed Central PMCID: PMC2743613.
3. Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, Devine DA, Lau J. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications. Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review. PubMed PMID: 17764220.
4. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2007 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2010. REFERENCE LINK
5. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD. REFERENCE LINK
6. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 Nov 4;149(9):627-37. Epub 2008 Oct 6. PubMed PMID: 18838716.
7. Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH; Dutch Lynch Syndrome Study Group, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010 Feb 3;102(3):193-201. Epub 2009 Dec 22. PubMed PMID: 20028993; PubMed Central PMCID: PMC2815724.
8. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009 Nov;137(5):1621-7. Epub 2009 Jul 18. PubMed PMID: 19622357; PubMed Central PMCID: PMC2767441.
9. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM; American College of Gastroenterology. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009 Mar;104(3):739-50. Epub 2009 Feb 24. Erratum in: Am J Gastroenterol. 2009 Jun;104(6):1613. PubMed PMID: 19240699.
10. National Cancer Center Network Guidelines Version 2.2011. REFERENCE LINK
11. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, The US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 May-Jun;58(3):130-60. Epub 2008 Mar 5. PubMed PMID: 18322143.
12. Overbeek LI, Ligtenberg MJ, Willems RW, Hermens RP, Blokx WA, Dubois SV, van der Linden H, Meijer JW, Mlynek-Kersjes ML, Hoogerbrugge N, Hebeda KM, van Krieken JH. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting. Am J Surg Pathol. 2008 Aug;32(8):1246-51. PubMed PMID: 18677806.
13. Engel C, Forberg J, Holinski-Feder E, Pagenstecher C, Plaschke J, Kloor M, Poremba C, Pox CP, Rüschoff J, Keller G, Dietmaier W, Rümmele P, Friedrichs N, Mangold E, Buettner R, Schackert HK, Kienle P, Stemmler S, Moeslein G, Loeffler M; German HNPCC Consortium. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer. 2006 Jan 1;118(1):115-22. PubMed PMID: 16003745.
14. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010 Feb;12(2):93-104. PubMed PMID: 20084010.
15. Institute of Medicine (US) Roundtable on Translating Genomic-Based Research for Health. The Value of Genetic and Genomic Technologies: Workshop Summary. Washington (DC): National Academies Press (US); 2010. PubMed PMID: 21391344.
16. Hall MJ. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients-will the ends justify the means? J Natl Compr Canc Netw. 2010 May;8(5):606-11. PubMed PMID: 20495087.
17. Peres J. To screen or not to screen for Lynch syndrome. J Natl Cancer Inst. 2010;102(18):1382-4. Epub 2010 Sep 8. PubMed PMID: 20826733.
18. Natarajan N, Watson P, Silva-Lopez E, Lynch HT. Comparison of extended colectomy and limited resection in patients with Lynch syndrome. Dis Colon Rectum. 2010 Jan;53(1):77-82. PubMed PMID: 20010355.
19. Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer. 2009;45(10):1890-6. Epub 2009 May 6. Review. PubMed PMID: 19427194.
20. Landsbergen KM, Prins JB, Brunner HG, Kraaimaat FW, Hoogerbrugge N. Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact. Fam Cancer. 2009;8(4):325-37. Epub 2009 Mar 28. Review. PubMed PMID: 19330464; PubMed Central PMCID: PMC2771129.
21. Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS. Lynch Syndrome Screening Implementation: Business Analysis by a Healthcare System. Am J Managed Care, 2011 Accepted for Publication